Expert consensus document: A consensus on the medical treatment of acromegaly

Nat Rev Endocrinol. 2014 Apr;10(4):243-8. doi: 10.1038/nrendo.2014.21. Epub 2014 Feb 25.


In March 2013, the Acromegaly Consensus Group met to revise and update guidelines for the medical treatment of acromegaly. The meeting comprised experts skilled in the medical management of acromegaly. The group considered treatment goals covering biochemical, clinical and tumour volume outcomes, and the place in guidelines of somatostatin receptor ligands, growth hormone receptor antagonists and dopamine agonists, and alternative modalities for treatment including combination therapy and novel treatments. This document represents the conclusions of the workshop consensus.

Publication types

  • Guideline
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acromegaly / drug therapy*
  • Acromegaly / etiology
  • Acromegaly / metabolism
  • Acromegaly / mortality
  • Acromegaly / surgery
  • Consensus
  • Human Growth Hormone / blood
  • Humans
  • Insulin-Like Growth Factor I / analysis
  • Pituitary Neoplasms / complications
  • Pituitary Neoplasms / drug therapy
  • Pituitary Neoplasms / mortality
  • Pituitary Neoplasms / surgery
  • Treatment Outcome


  • Human Growth Hormone
  • Insulin-Like Growth Factor I